Company profile CRDF
There is not enough data for Cardiff Oncology, Inc. to provide analysis
There is not enough data for Cardiff Oncology, Inc. to provide correlation calculation
There is not enough data for Cardiff Oncology, Inc. to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Onvansertib expected interest is significantly lower compared to same quarter last year (-100.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 28 | 77 175.0% QoQ | 352 357.1% QoQ | 123 -65.1% QoQ |
| 2020 | 113 303.6% YoY -8.1% QoQ | 316 310.4% YoY 179.6% QoQ | 196 -44.3% YoY -38.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 193 70.8% YoY inf% QoQ | 98 -69.0% YoY -49.2% QoQ | 300 53.1% YoY 206.1% QoQ | 237 inf% YoY -21.0% QoQ |
| 2022 | 233 20.7% YoY -1.7% QoQ | 133 35.7% YoY -42.9% QoQ | 258 -14.0% YoY 94.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 240 3.0% YoY inf% QoQ | 200 50.4% YoY -16.7% QoQ | 234 -9.3% YoY 17.0% QoQ | 0 -9.3% YoY -100.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Onvansertib was 12.76 per week. The last year interest of Onvansertib compared to the last 5 years has changed by -31.11%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -24.35%.
There is not enough data for Cardiff Oncology clinical trials to provide analysis
There is not enough data for Cardiff Oncology clinical trials to provide correlation calculation
There is not enough data for Cardiff Oncology clinical trials to provide analysis
There is not enough data for Cardiff Oncology stock price to provide analysis
There is not enough data for Cardiff Oncology stock price to provide correlation calculation
There is not enough data for Cardiff Oncology stock price to provide analysis
There is not enough data for Cardiff Oncology career to provide analysis
There is not enough data for Cardiff Oncology career to provide correlation calculation
There is not enough data for Cardiff Oncology career to provide analysis
There is not enough data for Solid tumor cancer treatment to provide analysis
There is not enough data for Solid tumor cancer treatment to provide correlation calculation
There is not enough data for Solid tumor cancer treatment to provide analysis
There is not enough data for Hematologic malignancies treatment to provide analysis
There is not enough data for Hematologic malignancies treatment to provide correlation calculation
There is not enough data for Hematologic malignancies treatment to provide analysis
After 39 days of this quarter the interest is at 273.0. Based on that we can calculate that during remaining 52 days it will total up to 637.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 419 | 598 42.7% QoQ | 538 -10.0% QoQ | 603 12.1% QoQ |
| 2020 | 688 64.2% YoY 14.1% QoQ | 633 5.9% YoY -8.0% QoQ | 510 -5.2% YoY -19.4% QoQ | 475 -21.2% YoY -6.9% QoQ |
| 2021 | 665 -3.3% YoY 40.0% QoQ | 494 -22.0% YoY -25.7% QoQ | 418 -18.0% YoY -15.4% QoQ | 532 12.0% YoY 27.3% QoQ |
| 2022 | 521 -21.7% YoY -2.1% QoQ | 546 10.5% YoY 4.8% QoQ | 685 63.9% YoY 25.5% QoQ | 565 6.2% YoY -17.5% QoQ |
| 2023 | 676 29.8% YoY 19.6% QoQ | 486 -11.0% YoY -28.1% QoQ | 586 -14.5% YoY 20.6% QoQ | 532 -5.8% YoY -9.2% QoQ |
| 2024 | 273 -59.6% YoY -48.7% QoQ | - | - | - |
The average 5 years interest of Biotechnology companies was 43.84 per week. The last year interest of Biotechnology companies compared to the last 5 years has changed by -0.55%. The interest for Biotechnology companies is seasonal. The last year interest is comparable to 5 years ago. It has changed only by -5.65%.
After 39 days of this quarter the interest is at 400.0. Based on that we can calculate that during remaining 52 days it will total up to 933.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 642 | 902 40.5% QoQ | 900 -0.2% QoQ | 943 4.8% QoQ |
| 2020 | 873 36.0% YoY -7.4% QoQ | 669 -25.8% YoY -23.4% QoQ | 751 -16.6% YoY 12.3% QoQ | 749 -20.6% YoY -0.3% QoQ |
| 2021 | 655 -25.0% YoY -12.6% QoQ | 643 -3.9% YoY -1.8% QoQ | 664 -11.6% YoY 3.3% QoQ | 711 -5.1% YoY 7.1% QoQ |
| 2022 | 885 35.1% YoY 24.5% QoQ | 877 36.4% YoY -0.9% QoQ | 862 29.8% YoY -1.7% QoQ | 907 27.6% YoY 5.2% QoQ |
| 2023 | 1009 14.0% YoY 11.2% QoQ | 908 3.5% YoY -10.0% QoQ | 940 9.0% YoY 3.5% QoQ | 1068 17.8% YoY 13.6% QoQ |
| 2024 | 400 -60.4% YoY -62.5% QoQ | - | - | - |
The average 5 years interest of Cancer research was 64.97 per week. The last year interest of Cancer research compared to the last 5 years has changed by 14.61%. The interest for Cancer research is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by 3.27%.
There is not enough data for Cardiff Oncology California to provide analysis
There is not enough data for Cardiff Oncology California to provide correlation calculation
There is not enough data for Cardiff Oncology California to provide analysis